simufilam

No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
BioSpace
Thu, 02/8/24 - 10:57 am
Cassava Sciences
Alzheimer's disease
clinical trials
simufilam
Cassava Defends Alzheimer’s Asset in Response to Data Manipulation Allegations
BioSpace
Fri, 10/13/23 - 10:24 am
Cassava Sciences
Alzheimer's diseases
simufilam
clinical trials
Why Shares of Cassava Sciences Are Dropping Wednesday
Motley Fool
Wed, 07/5/23 - 07:01 pm
Cassava Sciences
simufilam
Alzheimer's disease
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
BioSpace
Tue, 01/24/23 - 10:25 am
Cassava Sciences
clinical trials
simufilam
Alzheimer's disease
Cassava Files Defamation Suit against Short Sellers Linked to Data Manipulation Allegations - Updated
BioSpace
Fri, 11/4/22 - 10:16 am
Cassava Biosciences
legal
data manipulation
short sellers
simufilam
Alzheimer's disease
Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
Reuters
Wed, 07/27/22 - 10:56 am
Cassava Sciences
DOJ
data manipulation
Alzheimer's disease
simufilam
Cassava Faces Renewed Speculation Over Experimental Alzheimer’s Drug
BioSpace
Tue, 04/19/22 - 11:44 pm
Cassava Sciences
Alzheimer's disease
simufilam
Cassava 10K Filing Warns of Anticipated Hold, Paints Dire Picture of Alzheimer's Space
BioSpace
Thu, 03/3/22 - 10:23 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Fierce Biotech
Fri, 02/11/22 - 11:41 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Is Cassava Sciences Back in the Game?
Motley Fool
Tue, 09/28/21 - 10:54 am
FDA
Cassava Sciences
simufilam
Alzheimer's disease
Why Shares of Cassava Sciences Rose 15% Today
Motley Fool
Thu, 09/23/21 - 10:48 pm
Cassava Sciences
Alzheimer's disease
simufilam
NIH
Here's Why Cassava Sciences Is Having a Bad Day
Motley Fool
Wed, 08/25/21 - 12:19 pm
Cassava Sciences
FDA
citizen petitions
simufilam
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
Motley Fool
Thu, 08/12/21 - 12:11 am
Cassava Sciences
Alzheimer's disease
simufilam